Sign inJoin waitlistJoin the waitlist

Peter O'Donnell

Associate Professor of Medicine · Pritzker School of Medicine

Credentials: · · ·

History

Pritzker School of Medicine
Present
University of Chicago Medical Center
Present

University of Chicago Medical Center
2007–2009
Internal Medicine
University of Chicago Medical Center
2004–2007
UNC Hospitals
2003–2004
University of Chicago Division of the Biological Sciences, The Pritzker School of Medicine
1999–2003

Research

Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm,…
The Lancet · 2016 · 2,972 citations
First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2…
The Lancet Oncology · 2017 · 1,061 citations
Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma: Updated Results From a Phase 1/2 Open-label Study
JAMA Oncology · 2017 · 722 citations

Mark Ratain
46 papers
Walter Stadler
20 papers
David Meltzer
18 papers
JR
Jonathan Rosenberg
15 papers
Daniel Petrylak
14 papers
Matthew Galsky
14 papers
Joaquim Bellmunt
13 papers
Petros Grivas
13 papers
BB
Brittany Borden
11 papers
AB
Arjun Balar
10 papers
Matthew Milowsky
10 papers
Rita Nanda
10 papers

Grants

UG1 - NCTN (Network Lead)
National Cancer Institute · UG1
PI · $701.4K · University of Chicago
2019–2032
Clinical Therapeutics
National Institute of General Medical Sciences · T32
Contact PI · $3.7M · University of Chicago
1978–2030
Pharmacogenomics to Catalyze Decision Support in Oncology Care
National Human Genome Research Institute · R01
Contact PI · $3.5M · University of Chicago
2023–2028
Integrative Analyses of Clinical Pharmacogenetic Data to Prevent Hospital Readmission in Real-World Health Systems
National Human Genome Research Institute · R21
PI · $688K · Endeavor Health Clinical Operations
2024–2027

Clinical trials

Informing Pain Treatment Using Pharmacogenomic Analysis
Principal investigator · Recruiting
University of Chicago
2024–2028
The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care
Principal investigator · Suspended
University of Chicago
2022–2028
The ImPreSS Trial: Pharmacogenomic Decision Making at Time of Surgery
Principal investigator · Recruiting
University of Chicago
2019–2027
Implementation of Point-of-Care Pharmacogenomic Decision Support Accounting for Minority Disparities
Principal investigator · Recruiting
University of Chicago
2017–2028